Scientists and cancer physicians have successfully demonstrated the effectiveness of an advanced blood test for detecting and analyzing circulating tumor cells — breakaway cells from patients’ solid tumors — from cancer patients. The findings show that the highly sensitive blood analysis provides information that may soon be comparable to that from some types of surgical biopsies.